FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to pharmaceutical industry, namely: to particles of spherical shape; to a method for production thereof; to a drug preparation in a solid dosage form for treating or preventing type 2 diabetes mellitus, containing said particles and at least one pharmaceutically acceptable excipient. Disclosed particles have size of 1–100 mcm (defined with D (0.9)), contain amorphous empagliflozin and a pharmaceutically acceptable polymer selected from a homopolymer of polyvinylpyrrolidone and a copolymer of vinylpyrrolidone and vinyl acetate, and obtained by spray drying under certain conditions. According to the proposed method, empagliflozin is mixed with a polymer and a solvent, then obtained solution is dried by spraying at drying gas flow rate of 5–7 l/min, dissolved solid substances content of 15–40 mg/ml, using two-phase nozzle with diameter of 0.6–0.8 mm, at temperature of drying gas at inlet 90–110 °C, outlet temperature of 60–65 °C and rate of sprayed solution introduction is 5–7 ml/min.
EFFECT: group of inventions provides spherical particles with narrow size distribution and excellent physical properties for making solid dosage forms (flowability, tableting).
11 cl, 5 ex, 2 tbl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2809144C2 |
PROCESS FOR PREPARING HOMOGENOUS SPRAY-DRIED SOLID AMORPHOUS THERAPEUTICAL DISPERSE SYSTEMS USING SPRAYING PRESSURE NOZZLES (OPTIONS) AND PRODUCT | 2003 |
|
RU2288703C2 |
STABLE, COMPOSED OF PARTICLES PHARMACEUTICAL COMPOSITION, CONTAINING SOLIFENACIN OR ITS SALT | 2005 |
|
RU2397767C2 |
PHARMACEUTICAL COMPOSITION CONTAINING SOLID DISPERSIONS OF AMORPHOUS CLADRIBINE AND PHARMACEUTICALLY ACCEPTABLE WATER-SOLUBLE CARRIER | 2020 |
|
RU2748311C1 |
COMPOSITION OF THE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR | 2014 |
|
RU2661399C1 |
METHODS FOR SPRAY DRYING FOR PRODUCTION OF SOLID-AMORPHOUS DISPERSIONS OF DRUGS AND POLYMERS | 2004 |
|
RU2318495C2 |
ANTIFUNGAL DRY POWDERS | 2017 |
|
RU2766086C2 |
NEW FORM OF IVERMECTIN AND METHOD OF ITS PRODUCTION | 2019 |
|
RU2810145C2 |
SOLID DISPERSION | 2012 |
|
RU2648448C2 |
DEAMORPHIZATION OF SPRAY-DRIED FORMULATIONS VIA SPRAY-BLENDING | 2014 |
|
RU2698331C2 |
Authors
Dates
2020-02-05—Published
2019-04-11—Filed